Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoting Ma

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cancer|January 4, 2021
Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immunocheckpoint inhibitors for non-small cell lung cancer (NSCLC)Xiaoting Ma, Yujian Zhang, Shan Wang, et al.
Frontiers in Oncology|October 3, 2022
Application progress of liquid biopsy in gastric cancerXiaoting Ma, Kai Ou, Xiu Liu, et al.
Journal of Cancer|January 17, 2020
Efficacy of EGFR-TKIs with or without angiogenesis inhibitors in advanced non-small-cell lung cancer: A systematic review and meta-analysisZhaoxin Chen, Jia Wei, Xiaoting Ma, et al.
Clinical and Experimental Medicine|April 16, 2022
Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancerXiaoting Ma, Yujian Zhang, Cong Wang, et al.
Plos One|April 3, 2026
Ionic-liquid-facilitated transdermal absorption of lidocaine hydrochlorideXiaoting Ma, Yangzhe Zhou, Ke Jiang, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
The Predictors of Unsafe Behaviors among Nuclear Power Plant Workers: An Investigation Integrating Personality, Cognitive and Attitudinal FactorsDa Tao, Xiaofeng Diao, Xingda Qu, et al.
Journal of Cancer|February 3, 2021
Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic reviewXiaoting Ma, Yujian Zhang, Shan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 2, 2022
POLE/POLD1 mutation and tumor immunotherapyXiaoting Ma, Lin Dong, Xiu Liu, et al.
Translational Oncology|December 21, 2022
Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantationXin Jin, Xiaoting Ma, Dong Zhao, et al.
Journal of Cancer Research and Clinical Oncology|August 28, 2020
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)Xiaoting Ma, Shan Wang, Yujian Zhang, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cancer|January 4, 2021
Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immunocheckpoint inhibitors for non-small cell lung cancer (NSCLC)Xiaoting Ma, Yujian Zhang, Shan Wang, et al.
Frontiers in Oncology|October 3, 2022
Application progress of liquid biopsy in gastric cancerXiaoting Ma, Kai Ou, Xiu Liu, et al.
Journal of Cancer|January 17, 2020
Efficacy of EGFR-TKIs with or without angiogenesis inhibitors in advanced non-small-cell lung cancer: A systematic review and meta-analysisZhaoxin Chen, Jia Wei, Xiaoting Ma, et al.
Clinical and Experimental Medicine|April 16, 2022
Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancerXiaoting Ma, Yujian Zhang, Cong Wang, et al.
Plos One|April 3, 2026
Ionic-liquid-facilitated transdermal absorption of lidocaine hydrochlorideXiaoting Ma, Yangzhe Zhou, Ke Jiang, et al.
International Journal of Environmental Research and Public Health|January 8, 2023
The Predictors of Unsafe Behaviors among Nuclear Power Plant Workers: An Investigation Integrating Personality, Cognitive and Attitudinal FactorsDa Tao, Xiaofeng Diao, Xingda Qu, et al.
Journal of Cancer|February 3, 2021
Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic reviewXiaoting Ma, Yujian Zhang, Shan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 2, 2022
POLE/POLD1 mutation and tumor immunotherapyXiaoting Ma, Lin Dong, Xiu Liu, et al.
Translational Oncology|December 21, 2022
Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantationXin Jin, Xiaoting Ma, Dong Zhao, et al.
Journal of Cancer Research and Clinical Oncology|August 28, 2020
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)Xiaoting Ma, Shan Wang, Yujian Zhang, et al.
Pageof 8